1. Home
  2. BYND vs CDXS Comparison

BYND vs CDXS Comparison

Compare BYND & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$14.77

Market Cap

231.6M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.67

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYND
CDXS
Founded
2009
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Major Chemicals
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
231.6M
256.3M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
BYND
CDXS
Price
$14.77
$1.67
Analyst Decision
Sell
Analyst Count
7
0
Target Price
$0.83
N/A
AVG Volume (30 Days)
34.0M
1.6M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
24.69
43.82
EPS
N/A
N/A
Revenue
$275,496,000.00
$138,590,000.00
Revenue This Year
N/A
$7.73
Revenue Next Year
$1.36
$14.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$0.40
$0.96
52 Week High
$15.20
$2.98

Technical Indicators

Market Signals
Indicator
BYND
CDXS
Relative Strength Index (RSI) 88.60 47.41
Support Level $0.66 $1.57
Resistance Level N/A $1.75
Average True Range (ATR) 0.76 0.09
MACD 1.53 0.05
Stochastic Oscillator 95.81 87.93

Price Performance

Historical Comparison
BYND
CDXS

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: